AIM: The aim of this research is to assess the impact of COVID-19 on mortality rates among people in the United States with comorbid diabetes or cardiovascular disease (CVD)

METHODS: We utilized mortality data published by the Centers for Disease Control and Prevention for the years 2018–2021. Annual mortality rates were reported, including all-cause mortality, and mortality rates with COVID-19, diabetes and cardiovascular disease listed as a primary or underlying cause of death.

RESULT: Compared to 2018, there was a substantial increase in all-cause mortality across 2019, 2020 and 2021 respectively (0.9%, 18.4% and 20.3%). At the same time, we observed increased rates of CVD mortality (0.9%, 18.4% and 19.8%) and diabetes mortality (2.25% 39.7% and 42.7%).

CONCLUSION: We observed similar increases in the rates of all-cause mortality and CVD mortality in 2020 and 2021, but a more substantial increase in the rate of deaths among people with diabetes.